Skip to main
KYMR
KYMR logo

Kymera Therapeutics (KYMR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Kymera Therapeutics (KYMR) Stock

About Kymera Therapeutics (KYMR)

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
Market cap$2.84B
Today's volume1.01M
Revenue (TTM)$58.89M
Avg. daily volume962.82K
EBITDA (TTM)-$270.31M
Open$45.02
Price / earnings ratio-14.08x
Today's range$43.84 - $45.45
Debt / equity10.98x
52 week range$19.45 - $53.27
5 year debt / equity7.96x
Beta (LTM)1.75x
Interest coverage-1030.96x
Dividend & yield$0.00 (0.00%)
Current ratio8.49x
Ex-dividend date
Next earningsAug 6, 2025
Dividend payable date

Kymera Therapeutics Stock Rating

What analysts recommend for KYMR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 43%
Buy 39%
Hold 17%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for KYMR stock is $2.85B

The current P/E ratio for KYMR stock is -14.08

The 52-week high for KYMR stock is $53.27. The current KYMR stock price $undefined is 100.00% below its 52-week high

The 52-week low for KYMR stock is $19.45. The current KYMR stock price $undefined has increased 100.00% from its 52-week low

No, the KYMR stock does not pay dividends to its shareholders

The target price for KYMR stock is $54.30 based on the average of what a group of analyst think KYMR stock could be worth at a future date. This is not a prediction by Public.com

How to buy KYMR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KYMR stock

    Navigate to the Explore page. Then, type KYMR into the search bar. When you see KYMR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KYMR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Kymera Therapeutics Stock Earnings

The value each KYMR share was expected to gain vs. the value that each KYMR share actually gained.

Kymera Therapeutics (KYMR) reported Q1 2025 earnings per share (EPS) of -$0.82, beating estimates of -$0.91 by 9.89%. In the same quarter last year, Kymera Therapeutics's earnings per share (EPS) was -$0.69. Kymera Therapeutics is expected to release next earnings on 08/06/2025, with an earnings per share (EPS) estimate of -$0.86.

Buy Kymera Therapeutics (KYMR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.